Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 828 Views
-
Last post by NHE
-
- 0 Replies
- 2369 Views
-
Last post by frodo
-
- 0 Replies
- 1110 Views
-
Last post by NHE
-
- 0 Replies
- 1385 Views
-
Last post by frodo
-
- 1 Replies
- 1092 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1580 Views
-
Last post by NHE
-
- 0 Replies
- 2126 Views
-
Last post by vesta
-
- 1 Replies
- 1139 Views
-
Last post by Petr75